92 related articles for article (PubMed ID: 2481929)
1. Immunological changes following treatment of psoriasis with cyclosporin.
Tigalonowa M; Bjerke JR; Gallati H; Matre R
Acta Derm Venereol Suppl (Stockh); 1989; 146():142-5; discussion 146. PubMed ID: 2481929
[TBL] [Abstract][Full Text] [Related]
2. Assessment of epidermal dendritic cell markers and T-lymphocytes in psoriasis.
Jones JL; Berth-Jones J; Fletcher A; Hutchinson PE
J Pathol; 1994 Oct; 174(2):77-82. PubMed ID: 7525911
[TBL] [Abstract][Full Text] [Related]
3. Fc gamma-receptors in skin and serum from patients with psoriasis, before and after therapy.
Bjerke JR; Tigalonova M; Jensen TS; Matre R
Acta Derm Venereol Suppl (Stockh); 1994; 186():141-2. PubMed ID: 8073816
[TBL] [Abstract][Full Text] [Related]
4. Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment.
Baker BS; Swain AF; Griffiths CE; Leonard JN; Fry L; Valdimarsson H
Clin Exp Immunol; 1985 Sep; 61(3):526-34. PubMed ID: 3878241
[TBL] [Abstract][Full Text] [Related]
5. Fc gamma-receptor as a functional marker on epidermal Langerhans' cells in situ.
Tigalonowa M; Bjerke JR; Matre R
Acta Derm Venereol; 1989; 69(6):477-81. PubMed ID: 2481927
[TBL] [Abstract][Full Text] [Related]
6. Fc gamma-receptors and HLA-DR antigens on endothelial cells in psoriatic skin lesions.
Bjerke JR; Livden JK; Matre R
Acta Derm Venereol; 1988; 68(4):306-11. PubMed ID: 2459875
[TBL] [Abstract][Full Text] [Related]
7. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
Bovenschen HJ; Seyger MM; Van de Kerkhof PC
Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses: CD1a+, factor XIIIa+, and CD68+ cells in eczematous dermatitis, psoriasis, lichen planus and graft-versus-host disease.
Deguchi M; Aiba S; Ohtani H; Nagura H; Tagami H
Arch Dermatol Res; 2002 Oct; 294(7):297-302. PubMed ID: 12373334
[TBL] [Abstract][Full Text] [Related]
9. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
[TBL] [Abstract][Full Text] [Related]
10. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1.
Watabe D; Kanno H; Yoshida A; Kurose A; Akasaka T; Sawai T
Br J Dermatol; 2007 Aug; 157(2):259-65. PubMed ID: 17596165
[TBL] [Abstract][Full Text] [Related]
11. The role of lesional T cells in recalcitrant psoriasis during infliximab therapy.
Bovenschen HJ; Van De Kerkhof PC; Gerritsen WJ; Seyger MM
Eur J Dermatol; 2005; 15(6):454-8. PubMed ID: 16280298
[TBL] [Abstract][Full Text] [Related]
12. In situ characterization and counting of mononuclear cells in lesions of different clinical forms of psoriasis.
Bjerke JR
Acta Derm Venereol; 1982; 62(2):93-100. PubMed ID: 6179355
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A: preliminary results in the treatment of psoriasis.
Bonifati C; Clerico R; Potenza CM; Carlesimo M
Acta Derm Venereol Suppl (Stockh); 1989; 146():151-4. PubMed ID: 2532844
[TBL] [Abstract][Full Text] [Related]
14. Natural killer and natural killer-T cells in psoriasis.
Cameron AL; Kirby B; Fei W; Griffiths CE
Arch Dermatol Res; 2002 Nov; 294(8):363-9. PubMed ID: 12420105
[TBL] [Abstract][Full Text] [Related]
15. Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis.
Goedkoop AY; Kraan MC; Teunissen MB; Picavet DI; de Rie MA; Bos JD; Tak PP
Ann Rheum Dis; 2004 Jul; 63(7):769-73. PubMed ID: 15194570
[TBL] [Abstract][Full Text] [Related]
16. Expression of interleukin-6-like molecules and tumour necrosis factor after topical treatment of psoriasis with a new vitamin D analogue (MC 903).
Oxholm A; Oxholm P; Staberg B; Bendtzen K
Acta Derm Venereol; 1989; 69(5):385-90. PubMed ID: 2572101
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 in the epidermis of patients with psoriasis before and during PUVA treatment.
Oxholm A; Oxholm P; Staberg B; Bendtzen K
Acta Derm Venereol; 1989; 69(3):195-9. PubMed ID: 2566221
[TBL] [Abstract][Full Text] [Related]
18. Lymphocytes and macrophages of the epidermis and dermis in lesional psoriatic skin, but not epidermal Langerhans cells, are depleted by treatment with cyclosporin A.
Gupta AK; Baadsgaard O; Ellis CN; Voorhees JJ; Cooper KD
Arch Dermatol Res; 1989; 281(4):219-26. PubMed ID: 2673064
[TBL] [Abstract][Full Text] [Related]
19. Influence of systemic cyclosporin A on interleukin-2 and epidermal growth factor receptor expression in psoriatic skin lesions.
Horroccks A; Ormerod AD; Duncan JI; Thomson AW
Clin Exp Immunol; 1989 Nov; 78(2):166-71. PubMed ID: 12412743
[TBL] [Abstract][Full Text] [Related]
20. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
